HIALGAN amp. 10 mg. / Ml. 2 ml

INGREDIENTS:

Active substance: sodium hyaluronate,

Excipients: sodium chloride, sodium dihydrogen phosphate dihydrate, disodium phosphate and water for injection to a volume of 2 ml

Pharmacotherapeutic group and action:

The application of sodium hyaluronate in joints affected by arthritis visokoelastichnostta leads to normalization of the synovial fluid and activation processes of tissue repair in articular cartilage, which reduces pain and improves function in the joints.

INDICATION:

Traumatic and degenerative pathologies of the joints.

Aid in orthopedic surgery. 

CONTRAINDICATIONS:

Hypersensitivity to any of the ingredients or evidence of pre-existing allergies to chicken protein.

Patients with acute liver pathology.

PRECAUTIONS FOR USE:

Intraarticular administration should be performed by a qualified medical practitioner in accordance with the technique and aseptic conditions prescribed for such applications. It requires special precautions in patients with infection near the injection site to avoid the appearance of bacterial arthritis.

In the presence of effusion in the joint are recommended to aspirate before injecting HIALGAN.

DRUG INTERACTIONS:

Hyaluronic acid reacts with some local anesthetics, prolonging their effects.

DOSAGE, manner and time per application:

Unless your doctor advises otherwise, the usual dose is 2 ml Hialgan, weekly prodalzhanie articularly in 5 weeks.

SIDE EFFECTS:

Moderate, short-term pain immediately after injection can occur in rare cases injection site. If that occurs, the joint to remain at rest and apply ice locally.

With the appearance of visible signs of redness caused by the flow of hidden chronic inflammation, administration of hyaluronic acid may in some cases lead to deterioration.